Eswatini vs Tajikistan: Treatment success rate for patients treated for MDR-TB
Eswatini
86.0%
in 2022
Tajikistan
86.0%
in 2022
Eswatini rank
31st
Tajikistan rank
31st
Treatment success rate for patients treated for MDR-TB over time
- Eswatini
- Tajikistan
How they compare
Eswatini currently reports 86.0% against 86.0% in Tajikistan, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2009 it was Tajikistan ahead.
Eswatini ranks 31st and Tajikistan ranks 31st of 163 countries.
Across the 3 decades both report, Eswatini averaged higher in 1 and Tajikistan in 2.
Head to head by decade
| Decade | Eswatini | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 66.0% | 71.0% | 5.0% | Tajikistan |
| 2010s | 68.4% | 63.3% | 5.1% | Eswatini |
| 2020s | 82.7% | 84.0% | 1.3% | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Eswatini or Tajikistan?
- Eswatini, at 86.0% against 86.0% in Tajikistan as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Eswatini and Tajikistan?
- 0.0%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Tajikistan?
- 13 years are reported by both, from 2009 to 2022.
- How do Eswatini and Tajikistan rank globally for treatment success rate for patients treated for mdr-tb?
- Eswatini ranks 31st and Tajikistan ranks 31st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.